Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine

World Journal of Gastroenterology

Volumn 15, Issue 29, 2009, Pages 3603-3610

  Noureini, Sakineh Kazemi ^a   Wink, Michael ^b  

^a HAKIM SABZEVARI UNIVERSITY   (Iran)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Chelidonine; Inhibition; Senescence; Telomerase

Indexed keywords

BETA GALACTOSIDASE; CHELIDONINE; GLYCOPROTEIN P; NEUTRAL RED; PROTEIN BCL 2; TELOMERASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL STRAIN HEPG2; CHELIDONIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVITY; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; LD 50; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; STAINING; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOPHENANTHRIDINES; BETA-GALACTOSIDASE; CELL AGING; CELL LINE, TUMOR; CHELIDONIUM; DOWN-REGULATION; GENES, BCL-2; HUMANS; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERASE;

EID: 70349579537     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3603     Document Type: Article

References (36)

1. Niu CQ, He LY. Determination of isoquinoline alkaloids in Chelidonium majus L. by ion-pair high-performance liquid chromatography. J Chromatogr 1991; 542: 193-199
2. Colombo ML, Bosisio E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacol Res 1996; 33: 127-134
3. Biswas SJ, Bhattacharjee N, Khuda-Bukhsh AR. Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food Chem Toxicol 2008; 46: 1474-1487
4. Hohenwarter O, Strutzenberger K, Katinger H, Liepins A, Nowicky JW. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain. Drugs Exp Clin Res 1992; 18 Suppl: 1-4
5. Liepins A, Nowicky JW. Ukrain is selectively cytostatic and/or cytotoxic to human tumor and HIV-infected cells, but not to normal human cells. In: Adam D, Buchner T, Rubinstein E, eds. Recent Advances in Chemotherapy. Munich: Futuramed Publishers, 1992: 2660-2661
6. Gagliano N, Moscheni C, Torri C, Donetti E, Magnani I, Costa F, Nowicky W, Gioia M. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells. Anticancer Drugs 2007; 18: 669-676
7. Rosenkranz V, Wink M. Induction of apoptosis by alkaloids, non-protein amino acids, and cardiac glycosides in human promyelotic HL-60 cells. Z Naturforsch C 2007; 62: 458-466
8. Ernst E, Schmidt K. Ukrain - a new cancer cure? A systematic review of randomised clinical trials. BMC Cancer 2005; 5: 69
9. Kemeny-Beke A, Aradi J, Damjanovich J, Beck Z, Facsko A, Berta A, Bodnar A. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. Cancer Lett 2006; 237: 67-75
10. Panzer A, Joubert AM, Bianchi PC, Hamel E, Seegers JC. The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways. Eur J Cell Biol 2001; 80: 111-118
11. Philchenkov A, Kaminskyy V, Zavelevich M, Stoika R. Apoptogenic activity of two benzophenanthridine alkaloids from Chelidonium majus L. does not correlate with their DNA damaging effects. Toxicol In Vitro 2008; 22: 287-295
12. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-3262
13. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003; 5: 474-479
14. Huffman KE, Levene SD, Tesmer VM, Shay JW, Wright WE. Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang. J Biol Chem 2000; 275: 19719-19722
15. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-673
16. Shay JW, Wright WE. Telomerase: a target for cancer therapeutics. Cancer Cell 2002; 2: 257-265
17. Ludwig A, Saretzki G, Holm PS, Tiemann F, Lorenz M, Emrich T, Harley CB, von Zglinicki T. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res 2001; 61: 3053-3061
18. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Semin Cancer Biol 2000; 10: 399-406
19. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999; 5: 1164-1170
20. Hsu YH, Lin JJ. Telomere and telomerase as targets for anticancer and regeneration therapies. Acta Pharmacol Sin 2005; 26: 513-518
21. Kondo S, Kondo Y, Li G, Silverman RH, Cowell JK. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 1998; 16: 3323-3330
22. Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 2001; 20: 6958-6968
23. Nosrati M, Li S, Bagheri S, Ginzinger D, Blackburn EH, Debs RJ, Kashani-Sabet M. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clin Cancer Res 2004; 10: 4983-4990
24. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, Cunha GR, Blackburn EH. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 2004; 64: 4833-4840
25. Borenfreund E, Babich H, Martin-Alguacil N. Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell Dev Biol 1990; 26: 1030-1034
26. Gelmini S, Caldini A, Becherini L, Capaccioli S, Pazzagli M, Orlando C. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clin Chem 1998; 44: 2133-2138
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
28. Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann MM, Haefeli WE, Weiss J. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 2005; 70: 949-958
29. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367
30. Liepins A, Nowicky JW, Bustamante JO, Lam E. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570). Drugs Exp Clin Res 1996; 22: 73-79
31. Uglyanitsa KN, Nefyodov LI, Doroshenko YM, Nowicky JW, Volchek IV, Brzosko WJ, Hodysh YJ. Ukrain: a novel antitumor drug. Drugs Exp Clin Res 2000; 26: 341-356
32. Wu HL, Hsu CY, Liu WH, Yung BY. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 1999; 81: 923-929
33. Kaminskyy VO, Lootsik MD, Stoika RS. Correlation of the cytotoxic activity of four different alkaloids, from Chelidonium majus (greater celandine), with their DNA intercalating properties and ability to induce breaks in the DNA of NK/Ly murine lymphoma cells. Central European J Biology 2006; 1: 2-15
34. Habermehl D, Kammerer B, Handrick R, Eldh T, Gruber C, Cordes N, Daniel PT, Plasswilm L, Bamberg M, Belka C, Jendrossek V. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer 2006; 6: 14
35. Panzer A, Joubert AM, Bianchi PC, Seegers JC. The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro. Cancer Lett 2000; 150: 85-92
36. Kaminskyy V, Lin KW, Filyak Y, Stoika R. Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells. Cell Biol Int 2008; 32: 271-277